Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascular effects of rosiglitazone during elevated free fatty acid levels in healthy volunteers
2004-002243-27Phase 2Completed
- Sponsor
- Clinical Pharmacology
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of rosiglitazone in endothelial dysfunction and insulin resistance (IR), sponsored by Clinical Pharmacology. Primary endpoint: Forearm blood flow response. Started Oct 2004; status: completed.
02
Drugs
rosiglitazone
03
Conditions
endothelial dysfunctioninsulin resistance (IR)
Beyond the preview
Go deeper on 2004-002243-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002243-27.